FDA nixes unapproved gout treatment; Interpol at work in Russia;

> The FDA has ordered a halt to the marketing of unapproved single-ingredient oral colchicine, a gout treatment. FDA release

> In Russia, Interpol has begun a large-scale anti-counterfeiting operation. Article

> Varichem Pharma in Zimbabwe has become the third sub-Saharan Africa company to gain WHO prequalification for a medicines product. Article

> BioMimetic is bringing the manufacture of its first U.S. product in-house via a $20-million investment to double the footprint of its Nashville-area facility. Story

> Medicago, a maker of virus-like particle vaccines, held a groundbreaking ceremony last week in Research Triangle Park, NC, for a commercial grade facility. Medicago release

Suggested Articles

The cleaning procedures are so poor at a Zydus Cadila plant in India that the FDA says a sampling found 10 different cross-contaminated products.

Mylan is the most recent drugmaker facing the FDA's ire over a tainted API that led to a global recall of "sartan"-based drugs last year.

Merck MSD's $1.2 billion production restructuring has fallen on a site in France, where more than 200 manufacturing and R&D jobs will be swept away.